(4-methyl-1,3-thiazol-2-yl)methanol hydrochloride, 95.0%, 1g

H-LYS(TFA)-OH, 95%, 100g

1-Phenylsulfonylindole-5-boronic acid, 95.0%, 250mg

(2S,3aS,7aS)-1-(tert-Butoxycarbonyl)octahydro-1H-indole-2-carboxylic acid, 95.0%, 1g

Etilenglicol, min 99%, para síntesis, 1L, envase plástico.

N-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-amine, 95.0%, 5g

Citrato de plata 25 g

N1-(5-Chloropyridin-2-yl)-N2-((1S,2S,4R)-4-(dimethylcarbamoyl)-2-(5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine-2-carboxamido)cyclohexyl)oxalamide, 98%, 25mg

(Ethylenedinitrilo)tetraacetonitrile, 5g

4'-Propylacetophenone>95.0%(GC)500g

N-(6-Chloropyridazin-3-yl)acetamide, 95.0%, 5g

2-Fluoro-4-hydroxyacetophenone, 97.0%, 5g

trans-4-amino-3-(methoxy)tetrahydropyran hydrochloride, %, 5g